Ainos, Inc. financial data

Symbol
AIMD, AIMDW on Nasdaq
Industry
Pharmaceutical Preparations
Location
Ainos, Inc., 8880 Rio San Diego Drive Suite 800, San Diego, CA
State of incorporation
TX
Fiscal year end
December 31
Former names
AMARILLO BIOSCIENCES INC (to 3/30/2021)
Latest financial report
10-K - Q4 2024 - Mar 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 108 % -51%
Quick Ratio 3.46 % -88%
Debt-to-equity 63.1 % +236%
Return On Assets -47.4 % -17.4%
Operating Margin -14.7K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 15.4M shares
Common Stock, Shares, Outstanding 15.4M shares +230%
Entity Public Float 3.35M USD -35.8%
Common Stock, Value, Issued 154K USD +230%
Weighted Average Number of Shares Outstanding, Basic 9.5M shares +132%
Weighted Average Number of Shares Outstanding, Diluted 9.5M shares +132%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 93.7K USD -57.8%
Cost of Revenue 52.6K USD -86%
Research and Development Expense 8.41M USD +15%
Operating Income (Loss) -13.8M USD -4.81%
Nonoperating Income (Expense) -1.02M USD -81.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -14.9M USD -7.94%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -14.9M USD -7.93%
Earnings Per Share, Basic -1.56 USD/shares +53.6%
Earnings Per Share, Diluted -1.56 USD/shares +53.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.89M USD +106%
Accounts Receivable, after Allowance for Credit Loss, Current 56 USD -87.7%
Inventory, Net 144K USD -14.2%
Other Assets, Current 301K USD -28.2%
Assets, Current 4.34M USD +75.4%
Property, Plant and Equipment, Net 560K USD -36.2%
Intangible Assets, Net (Excluding Goodwill) 23.7M USD -16%
Other Assets, Noncurrent 174K USD -16.5%
Assets 28.8M USD -9.49%
Contract with Customer, Liability, Current 106K USD -5.53%
Liabilities, Current 3.95M USD +196%
Operating Lease, Liability, Noncurrent 3.28K USD
Other Liabilities, Noncurrent 349K USD +157%
Liabilities 13.3M USD +79.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -410K USD -51.4%
Retained Earnings (Accumulated Deficit) -52.7M USD -39.2%
Stockholders' Equity Attributable to Parent 15.5M USD -36.5%
Liabilities and Equity 28.8M USD -9.49%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.49M USD -4.37%
Net Cash Provided by (Used in) Financing Activities 778K USD -2.81%
Net Cash Provided by (Used in) Investing Activities -111K USD -53.5%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 15.4M shares +230%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -855K USD -20.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.89M USD +106%
Deferred Tax Assets, Valuation Allowance 9.14M USD +1.43%
Payments to Acquire Property, Plant, and Equipment 4.43K USD -93.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -15M USD -8.4%
Property, Plant and Equipment, Gross 1.68M USD -6.83%
Deferred Tax Assets, Operating Loss Carryforwards 6.91M USD -6.53%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Additional Paid in Capital 68.5M USD +9.54%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 9.14M USD +1.43%
Share-based Payment Arrangement, Expense 3.54M USD +218%
Interest Expense 48.7K USD +425%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%